Yasuhiro Kondoh

22.7k total citations · 1 hit paper
254 papers, 7.5k citations indexed

About

Yasuhiro Kondoh is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Yasuhiro Kondoh has authored 254 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Pulmonary and Respiratory Medicine, 55 papers in Physiology and 46 papers in Epidemiology. Recurrent topics in Yasuhiro Kondoh's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (182 papers), Sarcoidosis and Beryllium Toxicity Research (48 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers). Yasuhiro Kondoh is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (182 papers), Sarcoidosis and Beryllium Toxicity Research (48 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers). Yasuhiro Kondoh collaborates with scholars based in Japan, United States and Canada. Yasuhiro Kondoh's co-authors include Hiroyuki Taniguchi, Tomoki Kimura, Kensuke Kataoka, Osamu Nishiyama, Takeshi Johkoh, Yoshinori Hasegawa, Koji Sakamoto, Mituhiko Hisada, Arata Azuma and Kenzo Takagi and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yasuhiro Kondoh

237 papers receiving 7.3k citations

Hit Papers

Pirfenidone in idiopathic pulmonary fibrosis 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pirfenidone in idiopathic pulmonary fibrosis
    2009 686 citations Masahito Ebina, Yasuhiro Kondoh et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Kondoh Japan 44 6.3k 2.0k 1.0k 537 510 254 7.5k
Κατερίνα Αντωνίου Greece 45 4.6k 0.7× 1.7k 0.8× 800 0.8× 475 0.9× 331 0.6× 198 6.3k
Masahito Ebina Japan 41 3.6k 0.6× 1.5k 0.8× 1.5k 1.5× 252 0.5× 243 0.5× 97 7.2k
Thomas J. Richards United States 34 2.8k 0.4× 902 0.4× 473 0.5× 313 0.6× 391 0.8× 88 4.9k
Patrick Berger France 46 2.4k 0.4× 2.1k 1.1× 305 0.3× 157 0.3× 324 0.6× 249 6.6k
Ernest Cutz Canada 53 4.0k 0.6× 1.1k 0.6× 998 1.0× 282 0.5× 121 0.2× 255 10.3k
Kurt H. Albertine United States 48 4.0k 0.6× 792 0.4× 794 0.8× 85 0.2× 279 0.5× 199 8.0k
A. Coste France 42 1.8k 0.3× 1.3k 0.6× 366 0.4× 274 0.5× 169 0.3× 205 5.2k
Steven R. Duncan United States 37 2.1k 0.3× 709 0.4× 918 0.9× 286 0.5× 231 0.5× 86 4.5k
José Ramírez Spain 46 3.6k 0.6× 946 0.5× 1.0k 1.0× 237 0.4× 171 0.3× 174 6.6k
A Dewar United Kingdom 37 1.8k 0.3× 509 0.3× 620 0.6× 146 0.3× 280 0.5× 89 4.5k

Countries citing papers authored by Yasuhiro Kondoh

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Kondoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Kondoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Kondoh more than expected).

Fields of papers citing papers by Yasuhiro Kondoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Kondoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Kondoh. The network helps show where Yasuhiro Kondoh may publish in the future.

Co-authorship network of co-authors of Yasuhiro Kondoh

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Kondoh. A scholar is included among the top collaborators of Yasuhiro Kondoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Kondoh. Yasuhiro Kondoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bychkov, Andrey, Tomonori Tanaka, Shinobu Kunugi, et al.. (2025). Challenges in recognizing airway-centered fibrosis: Observer concordance and its role in fibrotic hypersensitivity pneumonitis. Respiratory Investigation. 63(3). 314–321.
2.
3.
4.
5.
Wells, Athol U., Simon Walsh, Ayodeji Adegunsoye, et al.. (2024). Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study. Respiratory Research. 25(1). 448–448. 3 indexed citations
6.
Sakao, Seiichiro, Yasuhiro Kondoh, Hideyuki Kinoshita, et al.. (2024). Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease. Respiratory Investigation. 62(6). 980–986. 3 indexed citations
7.
Matsuda, Toshiaki, Yasuhiro Kondoh, Reoto Takei, et al.. (2024). Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease. Respiratory Investigation. 62(6). 1088–1093. 2 indexed citations
8.
Inoue, Yoshikazu, Takashi Ogura, Arata Azuma, et al.. (2024). Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan. Advances in Therapy. 42(2). 1075–1093. 2 indexed citations
9.
Sumikawa, Hiromitsu, Kosaku Komiya, Ryoko Egashira, et al.. (2024). Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Respiratory Investigation. 62(5). 798–803.
10.
Furukawa, Taiki, Yasuhiro Kondoh, Masayuki Karasuyama, et al.. (2024). Deep Learning for Predicting Acute Exacerbation and Mortality of Interstitial Lung Disease. Annals of the American Thoracic Society. 22(5). 689–697. 1 indexed citations
11.
Takei, Reoto, Toshiaki Matsuda, Jun Fukihara, et al.. (2023). Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis. Frontiers in Medicine. 10. 1067149–1067149. 7 indexed citations
12.
Matsuda, Toshiaki, Yasuhiro Kondoh, Tomoki Kimura, et al.. (2023). Physical activity in idiopathic pulmonary fibrosis: Longitudinal change and minimal clinically important difference. Chronic Respiratory Disease. 20. 4073646138–4073646138. 1 indexed citations
13.
Ogura, Takashi, Yoshikazu Inoue, Arata Azuma, et al.. (2023). Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan. Advances in Therapy. 40(4). 1474–1493. 20 indexed citations
14.
15.
16.
Matsuda, Toshiaki, Yasuhiro Kondoh, Tomoki Kimura, et al.. (2021). Cutoff Points for Step Count to Predict 1-year All-Cause Mortality in Patients with Idiopathic Pulmonary Fibrosis. Respiration. 100(12). 1151–1157. 7 indexed citations
17.
Murota, Makiko, Takeshi Johkoh, Kyung Soo Lee, et al.. (2020). Influenza H1N1 virus-associated pneumonia often resembles rapidly progressive interstitial lung disease seen in collagen vascular diseases and COVID-19 pneumonia; CT-pathologic correlation in 24 patients. European Journal of Radiology Open. 7. 100297–100297. 2 indexed citations
18.
Fukihara, Jun, Koji Sakamoto, Junji Koyama, et al.. (2019). Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors. Clinical Lung Cancer. 20(6). 442–450.e4. 76 indexed citations
19.
Kondoh, Yasuhiro, Hiroyuki Taniguchi, Kensuke Kataoka, et al.. (2017). Disease severity staging system for idiopathic pulmonary fibrosis in Japan. Respirology. 22(8). 1609–1614. 20 indexed citations
20.
Ebina, Masahito, Yasuhiro Kondoh, Arata Azuma, et al.. (2009). Pirfenidone in idiopathic pulmonary fibrosis. European Respiratory Journal. 35(4). 821–829. 686 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Κατερίνα Αντωνίου Breakdown of academic impact, for papers by Masahito Ebina Breakdown of academic impact, for papers by Thomas J. Richards Breakdown of academic impact, for papers by Patrick Berger Breakdown of academic impact, for papers by Ernest Cutz Breakdown of academic impact, for papers by Kurt H. Albertine Breakdown of academic impact, for papers by A. Coste Breakdown of academic impact, for papers by Steven R. Duncan Breakdown of academic impact, for papers by José Ramírez Breakdown of academic impact, for papers by A Dewar
Rankless by CCL
2026